Drugs Made In America Acquisition II Corp.

Vine Hill Capital Investment Corp. IIVHCP · Asset ManagementFort Lauderdale, United States

74% matchPublic

Vine Hill Capital Investment Corp. II operates as a blank check enterprise, having been established on August 18, 2025, and maintains its principal office in Fort Lauderdale, FL. Its primary mission is to complete a business combination, which could involve activities such as a merger, capital stock exchange, asset acquisition, stock purchase, or corporate restructuring, with one or more other companies.

Texas Ventures Acquisition III Corp currently possesses no significant ongoing business activities. Its explicit objective is to facilitate a strategic business combination, which may take various forms such as a merger, an exchange of equity, an acquisition of assets, a stock purchase, or a corporate reorganization, with one or more existing enterprises. This entity was established in 2024 and is headquartered in Houston, Texas.

Lionheart Holdings, founded in 2024 and operating from Miami, Florida, is primarily engaged in pursuing and completing various forms of strategic business combinations. These transactions can include mergers, amalgamations, share exchanges, asset acquisitions, share purchases, reorganizations, or similar arrangements with one or more other enterprises.

Aldel Financial II Inc. presently operates without substantial commercial activities. Its core strategic objective is to complete a business combination with one or more entities, which may involve a merger, a share swap, an acquisition of assets, a stock purchase, a corporate restructuring, or another similar arrangement. This organization was founded in 2024 and maintains its principal office in Itasca, Illinois.

American Dynamism Acquisition Co. functions as a special purpose acquisition company (SPAC), specifically established to execute a business combination. Its primary objective involves identifying and finalizing a merger, an asset or share acquisition, a corporate restructuring, or a similar transaction with one or more existing enterprises. This company commenced operations on July 15, 2025, and maintains its headquarters in Washington, DC.

Currently, Perceptive Capital Solutions Corp possesses no significant active operations. Its principal objective is to execute a strategic business combination—such as a merger, share swap, asset procurement, equity acquisition, or corporate restructuring—with one or more enterprises or entities engaged in the life sciences and medical technology sectors. These prospective partners are sought exclusively within North America or Europe. The company was established in 2024, with its corporate base located in New York, New York.